Transaminase [aapp, enzy]
Levels [qlco]
Upper [spco]
Normal Range [qnco]
Oral [spco]
Hypoglycaemic drug [phsu]
therapy [ftcn]
Failure [ftcn]
Patients [podg]
Type 2 Diabetes [dsyn]
incident [idcn]
Diabetes [dsyn]
Worsening [qlco]
Diabetes [dsyn]
Recently [tmco]
Link [inpr]
hepatic steatosis [dsyn]
Study [mnob]
oral hypoglycemic agent [phsu]
Failure [ftcn]
Transaminase [aapp, enzy]
Levels [qlco]
Valid [qlco]
Measure [qnco]
liver steatosis [dsyn]
Select [acty]
Patients [podg]
attender [idcn]
Consecutive [qlco]
Annual [tmco]
Evaluations [ftcn]
Clinic [hcro, mnob]
Type 2 Diabetes [dsyn]
HYPOGLYCEMIC AGENTS, ORAL [phsu]
Failure [ftcn]
Responsive [ftcn]
Oral [spco]
therapy [ftcn]
Failure [ftcn]
therapy [ftcn]
Defined [cnce]
Glycated haemoglobin [aapp, bacs]
Maximal [qlco]
Dose [qnco]
Oral [spco]
therapy [ftcn]
Patient History [hlca]
Laboratory Data [idcn]
Compared [acty]
Oral [spco]
therapy [ftcn]
Responsive [ftcn]
Patients [podg]
Failure [ftcn]
Alanine Aminotransferase [aapp, enzy]
therapy [ftcn]
Failure [ftcn]
Likely [qlco]
symptoms [ftcn]
Hyperglycaemia [dsyn]
Diabetes [dsyn]
Regression Analysis [inpr]
Indicated [fndg]
Unit [qnco]
Transaminase [aapp, enzy]
Levels [qlco]
Increased [qnco]
HYPOGLYCEMIC AGENTS, ORAL [phsu]
Failure [ftcn]
Transaminase [aapp, enzy]
Levels [qlco]
Patients [podg]
Symptomatic [ftcn]
Hyperglycaemia [dsyn]
Diabetes [dsyn]
Associate [idcn]
oral hypoglycemic agent [phsu]
Failure [ftcn]
pathogenesis [ftcn]
Link [inpr]
Transaminase [aapp, enzy]
Declining [qlco]
function [phsf]
CONSIST [qlco]
Insulin Resistance [patf]
Increased [qnco]
Circulating [ftcn]
Fatty acid level [lbpr]
Causing [ftcn]
liver steatosis [dsyn]
Beta-cell dysfunction [fndg]
